Navigant Acquires Substantially All of the Assets of Quorum Consulting to Expand Its Life Sciences Practice and Overall Capabilities in Market Access
The addition of the experienced Quorum professionals, as well as the firm’s methodologies, expands Navigant’s capabilities in the life sciences industry. Quorum helps develop clinical evidence and outcomes data to support payer coverage policies and product adoption. Quorum’s services to clients include strategic product planning, reimbursement policy and government affairs, health economics and outcomes research, and market access programs.
“In today’s life sciences industry, it is critical that companies
understand the conditions necessary to optimize access. Quorum has
created a proven methodology to help clients achieve greater market
access for their innovations,” said
The Quorum team, including founder and CEO
“Data-driven decision-making and strategic planning pertaining to reimbursement, health economics and outcomes research, and market access is vital to the success of life sciences companies,” Tong said. “The addition of Quorum’s offerings to Navigant’s deep industry expertise will help enable our clients to capitalize on their market opportunity.”
About Navigant
View source version on businesswire.com: http://www.businesswire.com/news/home/20171102005142/en/
Source:
Navigant Investor Relations
Kyle Bland
312.573.5624
kyle.bland@navigant.com
or
Navigant
Corporate Communications
Belia Ortega
312.583.5703
belia.ortega@navigant.com